Goodes Prize Recipient Dr. Jeff Cummings' 2026 Alzheimer's Drug Pipeline Report Signals New Era of Biology-Driven Approaches

Findings validate the Alzheimer's Drug Discovery Foundation's long-standing leadership in advancing strategies that target the full pathobiology of the disease NEW YORK, May 5, 2026 /PRNewswire/ -- A new analysis of the Alzheimer's drug development pipeline, led by Goodes Prize winner and...